Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a
neurodegenerative disease characterized by the selective loss of particular groups of motor …

Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease
characterized by the selective death of lower motor neurons in the brain stem and spinal …

Spinal muscular atrophy (SMA) is an autosomal-recessive pediatric neurodegenerative
disease characterized by selective loss of spinal motor neurons. It is caused by mutation in …

The identification of noninvasive biomarkers to monitor the disease progression in spinal
muscular atrophy (SMA) is becoming increasingly important. MicroRNAs (miRNAs) regulate …

Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations in
survival motor neuron (SMN) 1 gene, resulting in a truncated SMN protein responsible for …

Two crucial questions in neuroscience are how neurons establish individual identity in the
developing nervous system and why only specific neuron subtypes are vulnerable to …

The availability of disease modifying therapies for spinal muscular atrophy (SMA) have
created an urgent need to identify clinically meaningful biomarkers that provide insight into …

Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by low levels of full-
length survival motor neuron (SMN) protein due to the loss of the survival motor neuron 1 …

Objective Spinal muscular atrophy (SMA) is a common genetic cause of infant mortality.
Nusinersen treatment ameliorates the clinical outcome of SMA, however, some patients …

Reduced expression of SMN protein causes spinal muscular atrophy (SMA), a
neurodegenerative disorder leading to motor neuron dysfunction and loss. However, the …